Marc Pawlitzki

3.2k total citations
81 papers, 1.1k citations indexed

About

Marc Pawlitzki is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Marc Pawlitzki has authored 81 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 32 papers in Neurology and 15 papers in Epidemiology. Recurrent topics in Marc Pawlitzki's work include Multiple Sclerosis Research Studies (38 papers), Peripheral Neuropathies and Disorders (19 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Marc Pawlitzki is often cited by papers focused on Multiple Sclerosis Research Studies (38 papers), Peripheral Neuropathies and Disorders (19 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Marc Pawlitzki collaborates with scholars based in Germany, Switzerland and Australia. Marc Pawlitzki's co-authors include Sven G. Meuth, Tobias Ruck, Leoni Rolfes, Heinz Wiendl, Steffen Pfeuffer, Lars Masanneck, Jens Neumann, Stefanie Schreiber, Catherine M. Sweeney‐Reed and Christopher Nelke and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Marc Pawlitzki

72 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Pawlitzki Germany 21 434 357 152 152 150 81 1.1k
Benjamin M. Jacobs United Kingdom 17 395 0.9× 377 1.1× 106 0.7× 176 1.2× 252 1.7× 50 1.3k
Mika Komori Japan 23 800 1.8× 317 0.9× 139 0.9× 202 1.3× 160 1.1× 59 1.4k
Anke Salmen Switzerland 17 546 1.3× 236 0.7× 102 0.7× 104 0.7× 107 0.7× 91 898
Cinzia Valeria Russo Italy 23 765 1.8× 381 1.1× 183 1.2× 92 0.6× 178 1.2× 61 1.3k
Robert Hoepner Switzerland 19 543 1.3× 324 0.9× 108 0.7× 169 1.1× 178 1.2× 96 1.1k
Anneke van der Walt Australia 23 893 2.1× 400 1.1× 187 1.2× 135 0.9× 172 1.1× 142 1.5k
Marcela Fiol Argentina 12 689 1.6× 263 0.7× 150 1.0× 272 1.8× 247 1.6× 25 1.2k
Jan‐Patrick Stellmann Germany 18 579 1.3× 232 0.6× 107 0.7× 192 1.3× 153 1.0× 49 1.1k
Julia Pakpoor United Kingdom 17 433 1.0× 248 0.7× 114 0.8× 191 1.3× 141 0.9× 35 1.0k
Ernestina Santos Portugal 19 455 1.0× 380 1.1× 189 1.2× 166 1.1× 115 0.8× 86 1.3k

Countries citing papers authored by Marc Pawlitzki

Since Specialization
Citations

This map shows the geographic impact of Marc Pawlitzki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Pawlitzki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Pawlitzki more than expected).

Fields of papers citing papers by Marc Pawlitzki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Pawlitzki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Pawlitzki. The network helps show where Marc Pawlitzki may publish in the future.

Co-authorship network of co-authors of Marc Pawlitzki

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Pawlitzki. A scholar is included among the top collaborators of Marc Pawlitzki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Pawlitzki. Marc Pawlitzki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 24(4). 103754–103754.
2.
Gall, Charlotte von, Nikos Werner, Gerd Meyer zu Hörste, et al.. (2025). Wearable Monitoring Captures Sleep Disturbances in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. Journal of the Peripheral Nervous System. 30(4). e70069–e70069.
3.
Dewilde, Sarah, Pierre Boulanger, R. C. Pardo, et al.. (2025). Caregiving burden among caregivers of people with myasthenia gravis. Orphanet Journal of Rare Diseases. 20(1). 311–311.
4.
Luchtmann, Michael, Daniel Behme, Jens Neumann, et al.. (2024). Risk factors for intracerebral hemorrhage in small-vessel disease and non-small-vessel disease etiologies—an observational proof-of-concept study. Frontiers in Neurology. 15. 1322442–1322442. 2 indexed citations
5.
Konen, Franz Felix, Konstantin Fritz Jendretzky, Ramona Schuppner, et al.. (2024). Ravulizumab in myasthenic crisis: the first case report. Journal of Neurology. 271(5). 2898–2901. 6 indexed citations
6.
Pfeuffer, Steffen, Marc Pawlitzki, Tobias Ruck, et al.. (2024). Abatacept Induces Long-Term Reconstitution of the B-Cell Niche in a Patient With CTLA-4 Haploinsufficiency. Neurology Neuroimmunology & Neuroinflammation. 12(2). e200351–e200351.
7.
Heidecke, Harald, M. Schott, Falk Steffen, et al.. (2024). Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS). Vaccines. 12(7). 790–790. 7 indexed citations
8.
Masanneck, Lars, et al.. (2024). Triage Performance Across Large Language Models, ChatGPT, and Untrained Doctors in Emergency Medicine: Comparative Study. Journal of Medical Internet Research. 26. e53297–e53297. 34 indexed citations
9.
Pfeuffer, Steffen, S. Wolff, Leoni Rolfes, et al.. (2024). Association of Clinical Relapses With Disease Outcomes in Multiple Sclerosis Patients Older Than 50 Years. Neurology. 103(2). e209574–e209574. 3 indexed citations
10.
Schroeter, Christina B., Corinna Preuße, Marc Pawlitzki, et al.. (2023). Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis. Acta Neuropathologica. 146(5). 725–745. 19 indexed citations
11.
Masanneck, Lars, Saskia Räuber, Christina B. Schroeter, et al.. (2023). Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany. Digital Health. 9. 589796701–589796701. 8 indexed citations
12.
Pawlitzki, Marc, Christina B. Schroeter, Orhan Aktaş, et al.. (2023). Immune Checkpoint Inhibition–Related Myasthenia-Myositis-Myocarditis Responsive to Complement Blockade. Neurology Neuroimmunology & Neuroinflammation. 11(1). 16 indexed citations
13.
Leßmann, Volkmar, et al.. (2023). Repurposing drugs against Alzheimer’s disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?. Journal of Neural Transmission. 130(8). 1003–1012. 14 indexed citations
14.
Räuber, Saskia, Marc Pawlitzki, Melanie Korsen, et al.. (2022). A national, multi-center study in Germany to assess implementation of infusion management, treatment satisfaction and quality of life in MS patients receiving alemtuzumab. Multiple Sclerosis and Related Disorders. 59. 103670–103670. 5 indexed citations
15.
Marina, Adela Della, Marc Pawlitzki, Tobias Ruck, et al.. (2021). Clinical Course, Myopathology and Challenge of Therapeutic Intervention in Pediatric Patients with Autoimmune-Mediated Necrotizing Myopathy. Children. 8(9). 721–721. 9 indexed citations
16.
Keller, Christian W., Marc Pawlitzki, Heinz Wiendl, & Jan D. Lünemann. (2021). Fc-Receptor Targeted Therapies for the Treatment of Myasthenia gravis. International Journal of Molecular Sciences. 22(11). 5755–5755. 16 indexed citations
17.
Pfeuffer, Steffen, Tobias Ruck, Refik Pul, et al.. (2021). Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Journal of Neurology Neurosurgery & Psychiatry. 92(9). 1007–1013. 20 indexed citations
18.
Rolfes, Leoni, Marc Pawlitzki, Steffen Pfeuffer, et al.. (2020). Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020. BioDrugs. 34(5). 587–610. 13 indexed citations
19.
Butryn, Michaela, Jens Neumann, Leoni Rolfes, et al.. (2020). Clinical, Radiological, and Laboratory Features of Spinal Cord Involvement in Primary Sjögren’s Syndrome. Journal of Clinical Medicine. 9(5). 1482–1482. 14 indexed citations
20.
Kaufmann, Joern, et al.. (2019). Anatomically constrained tractography facilitates biologically plausible fiber reconstruction of the optic radiation in multiple sclerosis. NeuroImage Clinical. 22. 101740–101740. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin M. Jacobs Breakdown of academic impact, for papers by Mika Komori Breakdown of academic impact, for papers by Anke Salmen Breakdown of academic impact, for papers by Cinzia Valeria Russo Breakdown of academic impact, for papers by Robert Hoepner Breakdown of academic impact, for papers by Anneke van der Walt Breakdown of academic impact, for papers by Marcela Fiol Breakdown of academic impact, for papers by Jan‐Patrick Stellmann Breakdown of academic impact, for papers by Julia Pakpoor Breakdown of academic impact, for papers by Ernestina Santos
Rankless by CCL
2026